 Entera Bio Ltd. ENTX announced today that Adam Gridley, CEO, and Dr. Phillip Schwartz, President of RD;, will present at the Ladenburg Thalmann 2019 Healthcare Conference on Tuesday, September 24, 2019 at 10:00 am Eastern Time. A live webcast of the presentation will be available via the Investor Relations page of the Entera Bio website, or by clicking here. A replay of the webcast will be archived on Entera website for approximately 45 days following the webcast. Entera Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in orphan indications and other areas with significant unmet medical needs. 